Education
About Us
Working with TipRanks
Follow Us
Regen Biopharma (RGBP)
OTHER OTC:RGBP
RGBP Stock Chart & Stats
$0.01
>-$0.01(-11.86%)
At close: 4:00 PM EST
$0.01
>-$0.01(-11.86%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.12
Previous CloseN/A
Volume4.72K
Average Volume (3M)586.57K
Market Cap
$907.66K
Enterprise ValueN/A
Total Cash (Recent Filing)$1.76K
Total Debt (Recent Filing)$1.04M
Price to Earnings (P/E)―
Beta0.61
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding108,054,700
10 Day Avg. Volume635,935
30 Day Avg. Volume586,565
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.08
Price to Sales (P/S)1.78
P/FCF Ratio-0.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Regen Biopharma News
RGBP FAQ
What was Regen Biopharma’s price range in the past 12 months?
Regen Biopharma lowest stock price was <$0.01 and its highest was $0.12 in the past 12 months.
What is Regen Biopharma’s market cap?
Regen Biopharma’s market cap is $907.66K.
When is Regen Biopharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regen Biopharma’s earnings last quarter?
Currently, no data Available
Is Regen Biopharma overvalued?
According to Wall Street analysts Regen Biopharma’s price is currently Overvalued.
Does Regen Biopharma pay dividends?
Regen Biopharma does not currently pay dividends.
What is Regen Biopharma’s EPS estimate?
Regen Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regen Biopharma have?
Regen Biopharma has 108,054,700 shares outstanding.
What happened to Regen Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Regen Biopharma?
Currently, no hedge funds are holding shares in RGBP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Regen Biopharma
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
Technical Analysis
Entero Therapeutics
―
Enveric Biosciences
―
Aditxt
―
Protagenic Therapeutics
―
PMGC Holdings
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---